SI1753764T1 - Derivati pirolopiridina - Google Patents

Derivati pirolopiridina

Info

Publication number: SI1753764T1
Authority: SI; Slovenia
Prior art keywords: pyrrolopyridine derivatives; pyrrolopyridine; derivatives
Prior art date: 2004-06-09

Application number

SI200530497T

Other languages

English (en)

Inventor

Andrew John Eatherton

Gerard Martin Paul Giblin

Matthew Russell Johnson

William Leonard Mitchell

Alcide Perboni

Brian Peter Slingsby

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-09

Filing date

2005-06-07

Publication date

2009-02-28

2004-06-09 Priority claimed from GB0412908A external-priority patent/GB0412908D0/en

2004-11-11 Priority claimed from GB0424950A external-priority patent/GB0424950D0/en

2005-06-07 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2009-02-28 Publication of SI1753764T1 publication Critical patent/SI1753764T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

SI200530497T 2004-06-09 2005-06-07 Derivati pirolopiridina SI1753764T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0412908A GB0412908D0 (en)	2004-06-09	2004-06-09	Compounds
GB0424950A GB0424950D0 (en)	2004-11-11	2004-11-11	Compounds
EP05747418A EP1753764B1 (en)	2004-06-09	2005-06-07	Pyrrolopyridine derivatives

Publications (1)

Publication Number	Publication Date
SI1753764T1 true SI1753764T1 (sl)	2009-02-28

Family

ID=34969264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200530497T SI1753764T1 (sl)	2004-06-09	2005-06-07	Derivati pirolopiridina

Country Status (25)

Country	Link
US (1)	US7589206B2 (sl)
EP (1)	EP1753764B1 (sl)
JP (1)	JP2008501758A (sl)
KR (1)	KR20070034049A (sl)
AR (1)	AR050158A1 (sl)
AT (1)	ATE412651T1 (sl)
AU (1)	AU2005251913A1 (sl)
BR (1)	BRPI0511874A (sl)
CA (1)	CA2569887A1 (sl)
DE (1)	DE602005010698D1 (sl)
DK (1)	DK1753764T3 (sl)
ES (1)	ES2317244T3 (sl)
HR (1)	HRP20090034T3 (sl)
IL (1)	IL179603A0 (sl)
MA (1)	MA28686B1 (sl)
MX (1)	MXPA06014471A (sl)
NO (1)	NO20070067L (sl)
PE (1)	PE20060430A1 (sl)
PL (1)	PL1753764T3 (sl)
PT (1)	PT1753764E (sl)
RU (1)	RU2006147278A (sl)
SI (1)	SI1753764T1 (sl)
TW (1)	TW200611695A (sl)
UY (1)	UY28945A1 (sl)
WO (1)	WO2005121140A1 (sl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20060100T3 (en)	2003-07-22	2007-03-31	Arena Pharmaceuticals Inc	Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
WO2005121140A1 (en)	2004-06-09	2005-12-22	Glaxo Group Limited	Pyrrolopyridine derivatives
ATE527258T1 (de) †	2004-07-28	2011-10-15	Takeda Pharmaceutical	Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
KR100958829B1 (ko) *	2004-09-03	2010-05-25	주식회사유한양행	피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
GB0516379D0 (en) *	2005-08-09	2005-09-14	Glaxo Group Ltd	Compounds
MX2008001935A (es) *	2005-08-09	2008-03-26	Glaxo Group Ltd	Derivados de imidazopiridina como ligandos del receptor de canabinoides.
WO2007118041A1 (en) *	2006-04-07	2007-10-18	Boehringer Ingelheim International Gmbh	Compounds which modulate the cb2 receptor
ES2389958T3 (es) *	2007-03-21	2012-11-05	Glaxo Group Limited	Uso de derivados de quinolina en el tratamiento del dolor
GB0705803D0 (en) *	2007-03-28	2007-05-02	Glaxo Group Ltd	Novel compounds
US9084742B2 (en)	2007-12-12	2015-07-21	Axovant Sciences Ltd.	Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-Quinoline
WO2009123714A2 (en)	2008-04-02	2009-10-08	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en)	2008-10-28	2010-06-03	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
JPWO2010113834A1 (ja)	2009-03-30	2012-10-11	アステラス製薬株式会社	ピリミジン化合物
TW201200518A (en) *	2010-03-10	2012-01-01	Kalypsys Inc	Heterocyclic inhibitors of histamine receptors for the treatment of disease
PT2599774T (pt) *	2010-07-29	2016-09-23	Astellas Pharma Inc	Compostos de piridina condensados como ligandos do recetor canabinoide cb2
WO2013140342A1 (en) *	2012-03-19	2013-09-26	Ariel-University Research And Development Company, Ltd.	Treatment of schizophrenia using beta-caryophyllene and cb2 receptor agonists
NZ754039A (en)	2013-06-26	2021-06-25	Abbvie Inc	Primary carboxamides as btk inhibitors
JP2018516992A (ja)	2015-06-12	2018-06-28	アクソファントサイエンシーズゲーエムベーハーＡｘｏｖａｎｔＳｃｉｅｎｃｅｓＧｍｂｈ	レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体
WO2017011767A2 (en)	2015-07-15	2017-01-19	Axovant Sciences Ltd.	Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of hallucinations associated with a neurodegenerative disease
WO2020112937A1 (en) *	2018-11-30	2020-06-04	Nimbus Lakshmi, Inc.	Tyk2 inhibitors and uses thereof
US11891394B1 (en)	2023-09-06	2024-02-06	King Faisal University	Pyrrolo[2,3-c][1,6]naphthyridine-8-carboxylic acid compounds as CK2 inhibitors
US11858935B1 (en)	2023-09-06	2024-01-02	King Faisal University	Pyrrolo[2,3-c][1,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0113245B1 (en) *	1982-12-29	1989-03-15	Kureha Kagaku Kogyo Kabushiki Kaisha	Cephalosporin derivatives
CA2031927A1 (en)	1989-12-27	1991-06-28	Imperial Oil Limited	Method for improving the activity maintenance of a plasma initiator
FI922347A0 (fi)	1990-01-05	1992-05-22	Pfizer	Azaoxindolderivat.
US5112820A (en) *	1990-03-05	1992-05-12	Sterling Drug Inc.	Anti-glaucoma compositions containing 2- and 3-aminomethyl-6-arylcarbonyl- or 6-phenylthio-2,3-dihydropyrrolo-(1,2,3-de)-1,4-benzoxazines and method of use thereof
GB9109246D0 (en)	1991-04-30	1991-06-19	Ici Plc	Nitrogen derivatives
DE4129603A1 (de)	1991-09-06	1993-03-11	Thomae Gmbh Dr K	Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
TW263504B (sl)	1991-10-03	1995-11-21	Pfizer
FR2692575B1 (fr)	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US5468757A (en)	1994-01-31	1995-11-21	Eli Lilly And Company	6-azaindole thromboxane synthase inhibitors
DE69502587T2 (de)	1994-02-18	1998-11-26	Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conn.	2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e] [1,4]diazepine und ihre verwendung zur vorbeugung und behandlung von hiv-infektion
GB9420521D0 (en)	1994-10-12	1994-11-30	Smithkline Beecham Plc	Novel compounds
US5589482A (en)	1994-12-14	1996-12-31	Pfizer Inc.	Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
JPH0920779A (ja)	1995-05-01	1997-01-21	Japan Tobacco Inc	縮合ヘテロ５員環アゼピン化合物類及びその医薬用途
GB9610811D0 (en)	1996-05-23	1996-07-31	Pharmacia Spa	Combinatorial solid phase synthesis of a library of indole derivatives
US6696448B2 (en)	1996-06-05	2004-02-24	Sugen, Inc.	3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
EP0927167A1 (en)	1996-08-14	1999-07-07	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists
TWI242011B (en)	1997-03-31	2005-10-21	Eisai Co Ltd	1,4-substituted cyclic amine derivatives
WO1998050356A1 (en)	1997-05-07	1998-11-12	Sugen, Inc.	2-indolinone derivatives as modulators of protein kinase activity
EP0931872B1 (de)	1998-01-23	2003-04-09	Voith Paper Patent GmbH	Verfahren zur Entfernung von feinen Verunreinigungen aus einer Faserstoffsuspension
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
JP2002523455A (ja)	1998-08-31	2002-07-30	スージェン・インコーポレーテッド	蛋白質キナーゼ活性の調節剤としての幾何学的に制限された２−インドリノン誘導体
GB9904995D0 (en)	1999-03-04	1999-04-28	Glaxo Group Ltd	Substituted aza-oxindole derivatives
WO2000053178A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
WO2000053180A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
AU3396000A (en)	1999-03-10	2000-09-28	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
CA2367116A1 (en)	1999-03-10	2000-09-14	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
EP1161431A4 (en)	1999-03-10	2002-04-24	Merck & Co Inc	6-AZAINDOL COMPOUNDS AS AN ANTAGONISTS OF THE GONADOTROPIN RELEASE HORMONES
AU3514200A (en)	1999-03-10	2000-09-28	Merck & Co., Inc.	6-azaindole compounds as antagonists of gonadotropin releasing hormone
WO2000075145A1 (en)	1999-06-03	2000-12-14	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
CA2390948A1 (en)	1999-06-03	2000-12-14	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
US6653304B2 (en)	2000-02-11	2003-11-25	Bristol-Myers Squibb Co.	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
US20020061892A1 (en)	2000-02-22	2002-05-23	Tao Wang	Antiviral azaindole derivatives
EP1132389A1 (en)	2000-03-06	2001-09-12	Vernalis Research Limited	New aza-indolyl derivatives for the treatment of obesity
NZ521978A (en)	2000-04-28	2004-10-29	Acadia Pharm Inc	Compounds that affect cholinergic receptors and are particularly muscarinic agonists
IL152477A0 (en)	2000-04-28	2003-05-29	Baxter Healthcare Sa	2-acyl indol derivatives and their use as anti-tumour agents
ES2262674T3 (es)	2000-08-14	2006-12-01	Ortho-Mcneil Pharmaceutical, Inc.	Pirazoles sustituidos.
US7332494B2 (en)	2000-08-14	2008-02-19	Janssen Pharmaceutica, N.V.	Method for treating allergies using substituted pyrazoles
US7342016B2 (en)	2000-08-30	2008-03-11	Schering Corporation	Farnesyl protein transferase inhibitors as antitumor agents
AU8873101A (en)	2000-09-06	2002-03-22	Ortho Mcneil Pharm Inc	A method for treating allergies using substituted pyrazoles
EP1315741A2 (en)	2000-09-06	2003-06-04	Ortho-McNeil Pharmaceutical, Inc.	A method for treating allergies
CA2424222A1 (en)	2000-10-02	2002-04-11	Merck & Co., Inc.	Inhibitors of prenyl-protein transferase
US6958358B2 (en)	2001-01-17	2005-10-25	Amura Therapeutics Limited	Inhibitors of cruzipain and other cysteine proteases
US20030207910A1 (en)	2001-02-02	2003-11-06	Tao Wang	Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
SK287900B6 (sk)	2001-02-02	2012-03-02	Bristol-Myers Squibb Company	Substituted azaindolexoacetic piperazine derivatives and pharmaceutical composition containing thereof
EP1377549A1 (en)	2001-03-12	2004-01-07	Millennium Pharmaceuticals, Inc.	Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
DK1385823T3 (da)	2001-04-09	2007-03-26	Novartis Vaccines & Diagnostic	Guanidinoforbindelser som melanocortin-4-receptor- (MC4-R) -agonister
CZ20033053A3 (en)	2001-05-14	2004-05-12	Bristol@Myersásquibbápharmaácompany	Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
AR035543A1 (es)	2001-06-26	2004-06-16	Japan Tobacco Inc	Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
WO2003009852A1 (en)	2001-07-24	2003-02-06	Merck & Co., Inc.	Tyrosine kinase inhibitors
DE10143079A1 (de)	2001-09-03	2003-05-15	Zentaris Ag	Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel
WO2003022214A2 (en)	2001-09-06	2003-03-20	Millennium Pharmaceuticals, Inc.	Piperazine and homopiperazine compounds
ES2278064T3 (es)	2001-10-19	2007-08-01	Transtech Pharma Inc.	Derivados de beta-carbolina como inhibidores de ptp.
DE10152306A1 (de)	2001-10-26	2003-07-24	Asta Medica Ag	2-Acylindolderivate mit neuen therapeutisch wertvollen Eigenschaften
TW200301251A (en)	2001-12-20	2003-07-01	Wyeth Corp	Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
US20030236277A1 (en)	2002-02-14	2003-12-25	Kadow John F.	Indole, azaindole and related heterocyclic pyrrolidine derivatives
WO2003080608A2 (en)	2002-03-27	2003-10-02	Glaxo Group Limited	Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
WO2003087087A2 (en)	2002-04-09	2003-10-23	Astex Technology Limited	Heterocyclic compounds and their use as modulators of p38 map kinase
US20040063744A1 (en)	2002-05-28	2004-04-01	Tao Wang	Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
UA78999C2 (en)	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6900206B2 (en)	2002-06-20	2005-05-31	Bristol-Myers Squibb Company	Indole, azaindole and related heterocyclic sulfonylureido piperazine derivatives
TW200403243A (en)	2002-07-18	2004-03-01	Wyeth Corp	1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
ATE323702T1 (de)	2002-08-06	2006-05-15	Astrazeneca Ab	Kondensierte pyridine und pyrimidine mit tie2 (tek) aktivität
WO2004018434A1 (en)	2002-08-21	2004-03-04	Glaxo Group Limited	Pyrimidine compounds
GB0222493D0 (en)	2002-09-27	2002-11-06	Glaxo Group Ltd	Compounds
EA200500584A1 (ru)	2002-09-30	2006-02-24	Дженелэбс Текнолоджиз, Инк.	Нуклеозидные производные для лечения инфекционных заболеваний, вызванных вирусом гепатита c
FR2845388B1 (fr)	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
MXPA05008441A (es)	2003-02-14	2005-10-19	Wyeth Corp	Derivados de heterociclil-3-sulfonilindazol o azaindazol como ligandos de 5-hidroxitriptamina-6.
US20040214856A1 (en)	2003-04-23	2004-10-28	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
WO2005121140A1 (en)	2004-06-09	2005-12-22	Glaxo Group Limited	Pyrrolopyridine derivatives

2005
- 2005-06-07 WO PCT/EP2005/006182 patent/WO2005121140A1/en not_active Ceased
- 2005-06-07 CA CA002569887A patent/CA2569887A1/en not_active Abandoned
- 2005-06-07 DE DE602005010698T patent/DE602005010698D1/de not_active Expired - Lifetime
- 2005-06-07 MX MXPA06014471A patent/MXPA06014471A/es unknown
- 2005-06-07 PE PE2005000651A patent/PE20060430A1/es not_active Application Discontinuation
- 2005-06-07 TW TW094118669A patent/TW200611695A/zh unknown
- 2005-06-07 US US11/570,099 patent/US7589206B2/en not_active Expired - Fee Related
- 2005-06-07 PT PT05747418T patent/PT1753764E/pt unknown
- 2005-06-07 AR ARP050102327A patent/AR050158A1/es unknown
- 2005-06-07 EP EP05747418A patent/EP1753764B1/en not_active Expired - Lifetime
- 2005-06-07 JP JP2007526300A patent/JP2008501758A/ja not_active Withdrawn
- 2005-06-07 KR KR1020077000449A patent/KR20070034049A/ko not_active Withdrawn
- 2005-06-07 HR HR20090034T patent/HRP20090034T3/xx unknown
- 2005-06-07 AT AT05747418T patent/ATE412651T1/de not_active IP Right Cessation
- 2005-06-07 ES ES05747418T patent/ES2317244T3/es not_active Expired - Lifetime
- 2005-06-07 AU AU2005251913A patent/AU2005251913A1/en not_active Abandoned
- 2005-06-07 RU RU2006147278/04A patent/RU2006147278A/ru not_active Application Discontinuation
- 2005-06-07 SI SI200530497T patent/SI1753764T1/sl unknown
- 2005-06-07 DK DK05747418T patent/DK1753764T3/da active
- 2005-06-07 UY UY28945A patent/UY28945A1/es unknown
- 2005-06-07 PL PL05747418T patent/PL1753764T3/pl unknown
- 2005-06-07 BR BRPI0511874-3A patent/BRPI0511874A/pt not_active IP Right Cessation
2006
- 2006-11-27 IL IL179603A patent/IL179603A0/en unknown
- 2006-12-28 MA MA29569A patent/MA28686B1/fr unknown
2007
- 2007-01-04 NO NO20070067A patent/NO20070067L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU2005251913A1 (en)	2005-12-22
PE20060430A1 (es)	2006-05-25
WO2005121140A1 (en)	2005-12-22
KR20070034049A (ko)	2007-03-27
ATE412651T1 (de)	2008-11-15
US7589206B2 (en)	2009-09-15
MXPA06014471A (es)	2007-03-21
NO20070067L (no)	2007-02-09
PL1753764T3 (pl)	2009-04-30
MA28686B1 (fr)	2007-06-01
ES2317244T3 (es)	2009-04-16
TW200611695A (en)	2006-04-16
US20070219229A1 (en)	2007-09-20
DE602005010698D1 (de)	2008-12-11
JP2008501758A (ja)	2008-01-24
EP1753764B1 (en)	2008-10-29
RU2006147278A (ru)	2008-07-20
DK1753764T3 (da)	2009-02-16
HK1104175A1 (en)	2008-01-04
PT1753764E (pt)	2009-01-28
IL179603A0 (en)	2007-05-15
HRP20090034T3 (en)	2009-03-31
CA2569887A1 (en)	2005-12-22
AR050158A1 (es)	2006-10-04
BRPI0511874A (pt)	2008-01-15
UY28945A1 (es)	2006-01-31
EP1753764A1 (en)	2007-02-21

Publication	Publication Date	Title
TWI369356B (en)	2012-08-01	Tetrahydropyridoindole derivatives
IL180481A0 (en)	2007-06-03	Aryl-pyridine derivatives
IL180331A0 (en)	2007-07-04	3-carbamoyl - 2 - pyridone derivative
IL179736A0 (en)	2007-05-15	Pyrrazolo-pyrimidine derivatives
IL182585A0 (en)	2007-07-24	Imidazo-benzodiazepine derivatives
IL183140A0 (en)	2007-09-20	Substituted benzoquinolizine derivatives
IL179603A0 (en)	2007-05-15	Pyrrolopyridine derivatives
IL183142A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
AP2074A (en)	2009-12-14	New 4-benzylidene-piperidin derivatives
IL183141A0 (en)	2007-09-20	New pyridothienopyrimidine derivatives
ZA200702066B (en)	2008-08-27	Halogenated benzmide derivatives
GB0414272D0 (en)	2004-07-28	OsK1 derivatives
IL177204A0 (en)	2006-12-10	Novel 4-benzimidazol -2-ylpyridazin -3- one derivatives
IL179444A0 (en)	2007-05-15	4-phenyl-pyrimidine-2-carbonitrile derivatives
TWI346109B (en)	2011-08-01	4-amino-5-cyanopyrimidine derivatives
IL182001A0 (en)	2007-07-04	2-acylaminothiazole derivatives
ZA200608769B (en)	2008-06-25	Imidazopyridine compound
ZA200609864B (en)	2008-08-27	Pyrrolopyridine derivatives
GB0422398D0 (en)	2004-11-10	Pyridopyrimidine derivatives
GB0405905D0 (en)	2004-04-21	Azaquinazoline derivatives
GB0422397D0 (en)	2004-11-10	3-Cyano-Quinoline derivatives
GB0422395D0 (en)	2004-11-10	Pyrimidopyrimidine derivatives
HUP0402371A2 (en)	2006-09-28	Novel 125-i-labeled amino-quinoline derivatives
GB0404801D0 (en)	2004-04-07	Bicyclic derivatives
PL367010A1 (en)	2005-10-17	Anti-recession preparation